PATENT CLAIM ANALYSIS

Application Number: 15979041
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "402000"]

Abstract:
The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.

Claim (Index 26):
The method of  claim 25  wherein the drug therapy comprises the administration of bisantrene and wherein the route of administration is selected from the group consisting of:\n (a) central venous administration; \n (b) intraperitoneal administration; \n (c) intravenous administration; \n (d) intravesicular administration for bladder cancer; \n (e) intrathecal administration; \n (f) intraarterial administration; \n (g) continuous infusion; and \n (h) intermittent infusion.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.31579
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14907728', '14907729', '13817096', '14753911', '14245738']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7896371906993912
- 35 USC 102 Novelty (BERT): 0.5346417957076876
- Combined Prediction Score: 0.7641376512002208
- Mean Citation Score: 267.787678
- Max Citation Score: 348.62634
- Similarity Product: 233.0579364562941

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test